APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rifapentine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Rifapentine Industry Growth and Trends Forecast to 2032

22 December 202593 pages

Choose your research edition.

Industry ResearchRifapentine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Rifapentine Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Rifapentine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rifapentine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Rifapentine Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Rifapentine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Rifapentine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Rifapentine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rifapentine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Rifapentine include Changzheng Pharma, Sine Pharma, Sanofi, MED-SHINE and Foutune Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Rifapentine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Rifapentine market size, estimates, and forecasts are presented in terms of sales volume (kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Rifapentine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Rifapentine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Rifapentine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Rifapentine Market by Company

Changzheng Pharma

Sine Pharma

Sanofi

MED-SHINE

Foutune Pharma

Rifapentine Segment by Type

20 Capsules/Box

24 Capsules/Box

Rifapentine Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Rifapentine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rifapentine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rifapentine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rifapentine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Rifapentine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Rifapentine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 20 Capsules/Box Table 2. Major Company of 24 Capsules/Box Table 3. Global Rifapentine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Rifapentine Sales by Type (2021-2026) & (kg) Table 5. Global Rifapentine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Rifapentine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Rifapentine Sales Market Share in Value by Type (2021-2026) Table 8. Global Rifapentine Price by Type (2021-2026) & (US$/kg) Table 9. Global Rifapentine Sales by Type (2027-2032) & (kg) Table 10. Global Rifapentine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Rifapentine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Rifapentine Sales Market Share in Value by Type (2027-2032) Table 13. Global Rifapentine Price by Type (2027-2032) & (US$/kg) Table 14. North America Rifapentine Sales by Type (2021-2026) & (kg) Table 15. North America Rifapentine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Rifapentine Sales by Type (2021-2026) & (kg) Table 17. Europe Rifapentine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Rifapentine Sales by Type (2021-2026) & (kg) Table 19. Asia-Pacific Rifapentine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Rifapentine Sales by Type (2021-2026) & (kg) Table 21. Latin America Rifapentine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Rifapentine Sales by Type (2021-2026) & (kg) Table 23. Middle East and Africa Rifapentine Sales by Type (2021-2026) & (US$ Million) Table 24. Rifapentine Industry Trends Table 25. Rifapentine Industry Drivers Table 26. Rifapentine Industry Opportunities and Challenges Table 27. Rifapentine Industry Restraints Table 28. Global Rifapentine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Rifapentine Revenue Market Share by Company (2021-2026) Table 30. Global Rifapentine Sales by Company (2021-2026) & (kg) Table 31. Global Rifapentine Sales Share by Company (2021-2026) Table 32. Global Rifapentine Market Price by Company (2021-2026) & (US$/kg) Table 33. Global Rifapentine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Rifapentine Major Company Production Sites and Headquarters Table 35. Global Rifapentine Company, Product Type & Application Table 36. Global Rifapentine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Rifapentine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Rifapentine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Rifapentine Sales by Region (2021-2026) & (kg) Table 41. Global Rifapentine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Rifapentine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Rifapentine Sales Market Share in Value by Region (2021-2026) Table 44. Global Rifapentine Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 45. Global Rifapentine Sales by Region (2027-2032) & (kg) Table 46. Global Rifapentine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Rifapentine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Rifapentine Sales Market Share in Value by Region (2027-2032) Table 49. Global Rifapentine Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2027-2032) Table 50. Global Rifapentine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Rifapentine Sales by Application (2021-2026) & (kg) Table 52. Global Rifapentine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Rifapentine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Rifapentine Sales Market Share in Value by Application (2021-2026) Table 55. Global Rifapentine Price by Application (2021-2026) & (US$/kg) Table 56. Global Rifapentine Sales by Application (2027-2032) & (kg) Table 57. Global Rifapentine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Rifapentine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Rifapentine Sales Market Share in Value by Application (2027-2032) Table 60. Global Rifapentine Price by Application (2027-2032) & (US$/kg) Table 61. North America Rifapentine Sales by Application (2021-2026) & (kg) Table 62. North America Rifapentine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Rifapentine Sales by Application (2021-2026) & (kg) Table 64. Europe Rifapentine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Rifapentine Sales by Application (2021-2026) & (kg) Table 66. Asia-Pacific Rifapentine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Rifapentine Sales by Application (2021-2026) & (kg) Table 68. Latin America Rifapentine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Rifapentine Sales by Application (2021-2026) & (kg) Table 70. Middle East and Africa Rifapentine Sales by Application (2021-2026) & (US$ Million) Table 71. Changzheng Pharma Company Information Table 72. Changzheng Pharma Business Overview Table 73. Changzheng Pharma Rifapentine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 74. Changzheng Pharma Rifapentine Product Portfolio Table 75. Changzheng Pharma Recent Development Table 76. Sine Pharma Company Information Table 77. Sine Pharma Business Overview Table 78. Sine Pharma Rifapentine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 79. Sine Pharma Rifapentine Product Portfolio Table 80. Sine Pharma Recent Development Table 81. Sanofi Company Information Table 82. Sanofi Business Overview Table 83. Sanofi Rifapentine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 84. Sanofi Rifapentine Product Portfolio Table 85. Sanofi Recent Development Table 86. MED-SHINE Company Information Table 87. MED-SHINE Business Overview Table 88. MED-SHINE Rifapentine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 89. MED-SHINE Rifapentine Product Portfolio Table 90. MED-SHINE Recent Development Table 91. Foutune Pharma Company Information Table 92. Foutune Pharma Business Overview Table 93. Foutune Pharma Rifapentine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 94. Foutune Pharma Rifapentine Product Portfolio Table 95. Foutune Pharma Recent Development Table 96. North America Rifapentine Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 97. North America Rifapentine Sales by Country (2021-2026) & (kg) Table 98. North America Rifapentine Sales Market Share by Country (2021-2026) Table 99. North America Rifapentine Sales Forecast by Country (2027-2032) & (kg) Table 100. North America Rifapentine Sales Market Share Forecast by Country (2027-2032) Table 101. North America Rifapentine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. North America Rifapentine Market Size by Country (2021-2026) & (US$ Million) Table 103. North America Rifapentine Market Share by Country (2021-2026) Table 104. North America Rifapentine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. North America Rifapentine Market Share Forecast by Country (2027-2032) Table 106. Europe Rifapentine Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 107. Europe Rifapentine Sales by Country (2021-2026) & (kg) Table 108. Europe Rifapentine Sales Market Share by Country (2021-2026) Table 109. Europe Rifapentine Sales Forecast by Country (2027-2032) & (kg) Table 110. Europe Rifapentine Sales Market Share Forecast by Country (2027-2032) Table 111. Europe Rifapentine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Europe Rifapentine Market Size by Country (2021-2026) & (US$ Million) Table 113. Europe Rifapentine Market Share by Country (2021-2026) Table 114. Europe Rifapentine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Europe Rifapentine Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Rifapentine Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Rifapentine Sales by Country (2021-2026) & (kg) Table 118. Asia-Pacific Rifapentine Sales Market Share by Country (2021-2026) Table 119. Asia-Pacific Rifapentine Sales Forecast by Country (2027-2032) & (kg) Table 120. Asia-Pacific Rifapentine Sales Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Rifapentine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Rifapentine Market Size by Country (2021-2026) & (US$ Million) Table 123. Asia-Pacific Rifapentine Market Share by Country (2021-2026) Table 124. Asia-Pacific Rifapentine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Asia-Pacific Rifapentine Market Share Forecast by Country (2027-2032) Table 126. Latin America Rifapentine Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 127. Latin America Rifapentine Sales by Country (2021-2026) & (kg) Table 128. Latin America Rifapentine Sales Market Share by Country (2021-2026) Table 129. Latin America Rifapentine Sales Forecast by Country (2027-2032) & (kg) Table 130. Latin America Rifapentine Sales Market Share Forecast by Country (2027-2032) Table 131. Latin America Rifapentine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Latin America Rifapentine Market Size by Country (2021-2026) & (US$ Million) Table 133. Latin America Rifapentine Market Share by Country (2021-2026) Table 134. Latin America Rifapentine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Latin America Rifapentine Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Rifapentine Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Rifapentine Sales by Country (2021-2026) & (kg) Table 138. Middle East and Africa Rifapentine Sales Market Share by Country (2021-2026) Table 139. Middle East and Africa Rifapentine Sales Forecast by Country (2027-2032) & (kg) Table 140. Middle East and Africa Rifapentine Sales Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Rifapentine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Rifapentine Market Size by Country (2021-2026) & (US$ Million) Table 143. Middle East and Africa Rifapentine Market Share by Country (2021-2026) Table 144. Middle East and Africa Rifapentine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Middle East and Africa Rifapentine Market Share Forecast by Country (2027-2032) Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Rifapentine Distributors List Table 149. Rifapentine Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Rifapentine Image Figure 2. Global Rifapentine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rifapentine Market Size (2021-2032) & (US$ Million) Figure 4. Global Rifapentine Sales (2021-2032) & (kg) Figure 5. 20 Capsules/Box Image Figure 6. Global 20 Capsules/Box Sales YoY Growth (2021-2032) & (kg) Figure 7. 24 Capsules/Box Image Figure 8. Global 24 Capsules/Box Sales YoY Growth (2021-2032) & (kg) Figure 9. Global Rifapentine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Rifapentine Market Share by Type 2025 VS 2032 Figure 11. North America Rifapentine Sales Market Share in Volume by Type in 2025 Figure 12. North America Rifapentine Sales Market Share in Value by Type in 2025 Figure 13. Europe Rifapentine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Rifapentine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Rifapentine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Rifapentine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Rifapentine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Rifapentine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Rifapentine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Rifapentine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Rifapentine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Retail Pharmacies Image Figure 24. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (kg) Figure 25. Online Pharmacies Image Figure 26. Global Online Pharmacies Sales YoY Growth (2021-2032) & (kg) Figure 27. Hospital Pharmacies Image Figure 28. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (kg) Figure 29. Global Rifapentine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Rifapentine Market Share by Application 2025 VS 2032 Figure 31. North America Rifapentine Sales Market Share in Volume by Application in 2025 Figure 32. North America Rifapentine Sales Market Share in Value by Application in 2025 Figure 33. Europe Rifapentine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Rifapentine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Rifapentine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Rifapentine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Rifapentine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Rifapentine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Rifapentine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Rifapentine Sales Market Share in Value by Application in 2025 Figure 41. North America Rifapentine Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 42. North America Rifapentine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Rifapentine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Rifapentine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Rifapentine Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 46. Europe Rifapentine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Rifapentine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Rifapentine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Rifapentine Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 50. Asia-Pacific Rifapentine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Rifapentine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Rifapentine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Rifapentine Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 54. Latin America Rifapentine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Rifapentine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Rifapentine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Rifapentine Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 58. Middle East and Africa Rifapentine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Rifapentine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Rifapentine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Rifapentine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Rifapentine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 20 Capsules/Box
  • 24 Capsules/Box
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Changzheng Pharma
  • Sine Pharma
  • Sanofi
  • MED-SHINE
  • Foutune Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Rifapentine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Rifapentine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Rifapentine Market by Type
  6. 1.3.1 20 Capsules/Box
  7. 1.3.2 24 Capsules/Box
  8. 1.4 Global Rifapentine Market Size by Type
  9. 1.4.1 Global Rifapentine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Rifapentine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Rifapentine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Rifapentine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Rifapentine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Rifapentine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Rifapentine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Rifapentine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Rifapentine Industry Trends
  2. 2.2 Rifapentine Industry Drivers
  3. 2.3 Rifapentine Industry Opportunities and Challenges
  4. 2.4 Rifapentine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Rifapentine Revenue (2021-2026)
  2. 3.2 Global Top Players by Rifapentine Sales (2021-2026)
  3. 3.3 Global Top Players by Rifapentine Price (2021-2026)
  4. 3.4 Global Rifapentine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Rifapentine Major Company Production Sites & Headquarters
  6. 3.6 Global Rifapentine Company, Product Type & Application
  7. 3.7 Global Rifapentine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Rifapentine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Rifapentine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Rifapentine Tier 1, Tier 2, and Tier 3
4 Rifapentine Regional Status and Outlook
  1. 4.1 Global Rifapentine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Rifapentine Historic Market Size by Region
  3. 4.2.1 Global Rifapentine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Rifapentine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Rifapentine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Rifapentine Forecasted Market Size by Region
  7. 4.3.1 Global Rifapentine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Rifapentine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Rifapentine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Rifapentine by Application
  1. 5.1 Rifapentine Market by Application
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Rifapentine Market Size by Application
  6. 5.2.1 Global Rifapentine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Rifapentine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Rifapentine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Rifapentine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Rifapentine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Rifapentine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Rifapentine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Rifapentine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Changzheng Pharma
  2. 6.1.1 Changzheng Pharma Company Information
  3. 6.1.2 Changzheng Pharma Business Overview
  4. 6.1.3 Changzheng Pharma Rifapentine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Changzheng Pharma Rifapentine Product Portfolio
  6. 6.1.5 Changzheng Pharma Recent Developments
  7. 6.2 Sine Pharma
  8. 6.2.1 Sine Pharma Company Information
  9. 6.2.2 Sine Pharma Business Overview
  10. 6.2.3 Sine Pharma Rifapentine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sine Pharma Rifapentine Product Portfolio
  12. 6.2.5 Sine Pharma Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Rifapentine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Rifapentine Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 MED-SHINE
  20. 6.4.1 MED-SHINE Company Information
  21. 6.4.2 MED-SHINE Business Overview
  22. 6.4.3 MED-SHINE Rifapentine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 MED-SHINE Rifapentine Product Portfolio
  24. 6.4.5 MED-SHINE Recent Developments
  25. 6.5 Foutune Pharma
  26. 6.5.1 Foutune Pharma Company Information
  27. 6.5.2 Foutune Pharma Business Overview
  28. 6.5.3 Foutune Pharma Rifapentine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Foutune Pharma Rifapentine Product Portfolio
  30. 6.5.5 Foutune Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Rifapentine Sales by Country
  2. 7.1.1 North America Rifapentine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Rifapentine Sales by Country (2021-2026)
  4. 7.1.3 North America Rifapentine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Rifapentine Market Size by Country
  6. 7.2.1 North America Rifapentine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Rifapentine Market Size by Country (2021-2026)
  8. 7.2.3 North America Rifapentine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Rifapentine Sales by Country
  2. 8.1.1 Europe Rifapentine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Rifapentine Sales by Country (2021-2026)
  4. 8.1.3 Europe Rifapentine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Rifapentine Market Size by Country
  6. 8.2.1 Europe Rifapentine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Rifapentine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Rifapentine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Rifapentine Sales by Country
  2. 9.1.1 Asia-Pacific Rifapentine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Rifapentine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Rifapentine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Rifapentine Market Size by Country
  6. 9.2.1 Asia-Pacific Rifapentine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Rifapentine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Rifapentine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Rifapentine Sales by Country
  2. 10.1.1 South America Rifapentine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Rifapentine Sales by Country (2021-2026)
  4. 10.1.3 South America Rifapentine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Rifapentine Market Size by Country
  6. 10.2.1 South America Rifapentine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Rifapentine Market Size by Country (2021-2026)
  8. 10.2.3 South America Rifapentine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Rifapentine Sales by Country
  2. 11.1.1 Middle East and Africa Rifapentine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Rifapentine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Rifapentine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Rifapentine Market Size by Country
  6. 11.2.1 Middle East and Africa Rifapentine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Rifapentine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Rifapentine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Rifapentine Value Chain Analysis
  2. 12.1.1 Rifapentine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Rifapentine Production Mode & Process
  7. 12.2 Rifapentine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Rifapentine Distributors
  10. 12.2.3 Rifapentine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst